{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:52:51Z","timestamp":1792446771943,"version":"4.5.0"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015930","name":"Equity Trustees Hld Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012599","name":"Bethlehem Griffiths Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neubiorev.2025.106276","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:17:48Z","timestamp":1751545068000},"page":"106276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders"],"prefix":"10.1016","volume":"176","author":[{"given":"Sujan Kumar","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Gubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-8922","authenticated-orcid":false,"given":"Anthony J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib1","first-page":"1","article-title":"Gut microbiome is not associated with mild cognitive impairment in Parkinson\u2019s disease","volume":"10:1","author":"Aho","year":"2024","journal-title":"Npj Park\u2019S. Dis."},{"key":"10.1016\/j.neubiorev.2025.106276_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102119","article-title":"Evaluation and targeting of amyloid precursor protein (APP)\/amyloid beta (A\u03b2) axis in amyloidogenic and non-amyloidogenic pathways: a time outside the tunnel","volume":"92","author":"Al-kuraishy","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neubiorev.2025.106276_bib3","unstructured":"Alzheimer\u2019s disease - NHS . (2021). https:\/\/www.nhs.uk\/conditions\/alzheimers-disease\/."},{"key":"10.1016\/j.neubiorev.2025.106276_bib4","unstructured":"Alzheimer\u2019s disease | Dementia Australia . (2023). https:\/\/www.dementia.org.au\/about-dementia\/alzheimers-disease#causes-of-alzheimer%E2%80%99s-disease."},{"key":"10.1016\/j.neubiorev.2025.106276_bib5","unstructured":"Alzheimer\u2019s Disease Fact Sheet | National Institute on Aging. (2021). https:\/\/web.archive.org\/web\/20220323200727\/https:\/\/www.nia.nih.gov\/health\/alzheimers-disease-fact-sheet."},{"key":"10.1016\/j.neubiorev.2025.106276_bib6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3389\/fimmu.2017.01529","article-title":"Modulation of P2X7 receptor during inflammation in multiple sclerosis","volume":"8","author":"Amadio","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s12602-025-10576-5","article-title":"Bifidobacterium breve BBr60 enhances SCFA levels and restores NLRP3\/NLRP6 balance in the gut to improve motor deficits in PD Mice","author":"An","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib8","article-title":"Plasma-borne indicators of inflammasome activity in Parkinson\u2019s disease patients","volume":"7","author":"Anderson","year":"2021","journal-title":"NPJ Park. \u2019S. Dis."},{"issue":"20","key":"10.1016\/j.neubiorev.2025.106276_bib9","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1093\/hmg\/ddt259","article-title":"Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Apolloni","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106276_bib10","first-page":"1101","article-title":"Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Apolloni","year":"2014","journal-title":"Dis. Models Mech."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106276_bib11","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.4049\/jimmunol.1203262","article-title":"The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis","volume":"190","author":"Apolloni","year":"2013","journal-title":"J. immunol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/d41591-020-00003-3","article-title":"What part does the gut play in Parkinson\u2019s disease?","author":"Arnold","year":"2020","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/path.5846","article-title":"NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis","volume":"256","author":"Banerjee","year":"2022","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib14","article-title":"P2X7 antagonism using brilliant blue G reduces body weight loss and prolongs survival in female SOD1G93A amyotrophic lateral sclerosis mice","volume":"2017","author":"Bartlett","year":"2017","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib15","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1007\/s12035-017-0502-x","article-title":"Peroxynitrite activates the NLRP3 inflammasome Cascade in SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"55","author":"Bellezza","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbi.2023.09.011","article-title":"P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes","volume":"114","author":"Beltran-Lobo","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106276_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039576","article-title":"Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling","volume":"7","author":"Beynon","year":"2012","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.52016","article-title":"Associations of inflammatory cytokines and cortisol with nonmotor features of Huntington\u2019s disease","volume":"11","author":"Bilal","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"7770","key":"10.1016\/j.neubiorev.2025.106276_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","article-title":"Potential roles of gut microbiome and metabolites in modulating ALS in mice","volume":"572","author":"Blacher","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106276_bib20","first-page":"14","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106276_bib21","first-page":"11","article-title":"ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles","author":"Bonafede","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106276_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural Transm."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106276_bib23","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1111\/ene.15594","article-title":"Gut microbiota analysis in pediatric-onset multiple sclerosis compared to pediatric monophasic demyelinating syndromes and pediatric controls","volume":"30","author":"Bruijstens","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01447-z","article-title":"NLRP3 exacerbates EAE severity through ROS-dependent NET formation in the mouse brain","volume":"22","author":"Byun","year":"2024","journal-title":"Cell Communication Signaling CCS"},{"issue":"6704","key":"10.1016\/j.neubiorev.2025.106276_bib25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/27351","article-title":"Neuron loss in APP transgenic mice","volume":"395","author":"Calhoun","year":"1998","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2025.106276_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jneuroim.2012.02.002","article-title":"Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis","volume":"245","author":"Caragnano","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.01.045","article-title":"The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis","volume":"81","author":"Carmo","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2025.106276_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2025.106276_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tox.2013.04.004","article-title":"Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism","volume":"311","author":"Cervetto","year":"2013","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02419-9","article-title":"A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington\u2019s disease","volume":"19","author":"Chen","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neubiorev.2025.106276_bib31","first-page":"12","article-title":"Understanding the role of purinergic P2X7 receptors in the gastrointestinal system: a systematic review","author":"Cheng","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.neubiorev.2025.106276_bib32","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","article-title":"Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695","volume":"276","author":"Chishti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2025.106276_bib33","unstructured":"ClinicalTrialsArena. (2024, March 8). NodThera\u2019s NT-0796 Shows Promise in Parkinson\u2019s Disease Trial. \u3008https:\/\/www.clinicaltrialsarena.com\/news\/nodthera-parkinsons-disease-trial\/?utm_source=chatgpt.com&cf-view&cf-closed\u3009."},{"key":"10.1016\/j.neubiorev.2025.106276_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. rev. immunol."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106276_bib35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.tips.2017.07.005","article-title":"Early and late CNS inflammation in Alzheimer\u2019s disease: two extremes of a continuum?","volume":"38","author":"Cuello","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106276_bib36","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.0901212","article-title":"The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis","volume":"183","author":"D\u2019Ambrosi","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bpa.12467","article-title":"Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice","volume":"28","author":"Debye","year":"2018","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib38","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1074\/jbc.M110.200618","article-title":"The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein","volume":"286","author":"Delarasse","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2025.106276_bib39","unstructured":"Dementia Fact Sheet, World Health Organization (WHO). (2023). \u3008https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/dementia\u3009."},{"key":"10.1016\/j.neubiorev.2025.106276_bib40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.23728","article-title":"The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins","volume":"68","author":"Deora","year":"2020","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106276_bib42","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04492-y","article-title":"A\u03b21-42 peptides blunt the adenosine A2A receptor-mediated control of the interplay between P2X7 and P2Y1 receptors mediated calcium responses in astrocytes","volume":"79","author":"Dias","year":"2022","journal-title":"Cell. Mol. Life Sci. CMLS"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106276_bib43","first-page":"1893","article-title":"Altered P2X7-receptor level and function in mouse models of Huntington\u2019s disease and therapeutic efficacy of antagonist administration","volume":"23","author":"D\u00edaz-Hern\u00e1ndez","year":"2009","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib44","first-page":"155","article-title":"Analysis of inflammasomes and CYP27B1 genes in cuprizone demyelinated C57BL\/6 mice and evaluation of Th1 and Th2 patterns after oral administration of Lactobacillus casei strain T2 (IBRC-M10783","author":"Digehsara","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.neubiorev.2025.106276_bib45","first-page":"11","article-title":"Altered gut microbiota related to inflammatory responses in patients with Huntington\u2019s disease","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pharmthera.2019.03.005","article-title":"Gene-environment interactions in Alzheimer\u2019s Disease: a potential path to precision medicine","volume":"199","author":"Eid","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2025.106276_bib47","article-title":"The microbiota\u2013gut\u2013brain axis in Huntington\u2019s disease: pathogenic mechanisms and therapeutic targets","author":"Ekwudo","year":"2024","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/gutjnl-2021-326023","article-title":"Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria","volume":"72","author":"Esteves","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10455","article-title":"Heat-killed Lactobacillus murinus confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome","volume":"8","author":"Fan","year":"2022","journal-title":"Bioeng. Transl. Med."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106276_bib51","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/cns.12983","article-title":"Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP\/PS1 transgenic mice","volume":"24","author":"Feng","year":"2018","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11011-019-00512-2","article-title":"Increased inflammation in BA21 brain tissue from African Americans with Alzheimer\u2019s disease","volume":"35","author":"Ferguson","year":"2020","journal-title":"Metab. Brain Dis."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106276_bib53","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bbadis.2017.03.004","article-title":"P2X7 receptor promotes intestinal inflammation in chemically induced colitis and triggers death of mucosal regulatory T cells","volume":"1863","author":"Figliuolo","year":"2017","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106276_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/life11070620","article-title":"Comparison of the intestinal microbiome of italian patients with multiple Sclerosis and their household relatives","volume":"11","author":"Galluzzo","year":"2021","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jnc.12286","article-title":"P2X7 receptor-induced death of motor neurons by a peroxynitrite\/FAS-dependent pathway","volume":"126","author":"Gandelman","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2025.106276_bib56","first-page":"7","article-title":"Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis","author":"Gandelman","year":"2010","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib57","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1474-4422(13)70026-7","article-title":"Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment","volume":"12","author":"Goldstein","year":"2013","journal-title":"Lancet Neurol."},{"issue":"465","key":"10.1016\/j.neubiorev.2025.106276_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106276_bib59","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/1028415X.2022.2110189","article-title":"The gut microbiome and cognition in Parkinson\u2019s disease: a systematic review","volume":"26","author":"Grant","year":"2023","journal-title":"Nutr. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib60","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.0904145","article-title":"NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses","volume":"185","author":"Gris","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41582-018-0103-y","article-title":"Amyotrophic lateral sclerosis - a multisystem neurodegenerative disorder","volume":"15","author":"Grossman","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib62","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11302-018-9620-9","article-title":"Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries","volume":"14","author":"Grygorowicz","year":"2018","journal-title":"Purinergic Signal."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.55782\/ane-2011-1823","article-title":"Expression of purinergic P2X7 receptor in rat brain during the symptomatic phase of experimental autoimmune encephalomyelitis and after recovery of neurological deficits","volume":"71","author":"Grygorowicz","year":"2011","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.neubiorev.2025.106276_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2016.02.003","article-title":"Early P2X7R-related astrogliosis in autoimmune encephalomyelitis","volume":"74","author":"Grygorowicz","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac205","article-title":"Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington\u2019s disease mice","volume":"4","author":"Gubert","year":"2022","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10753-017-0667-5","article-title":"NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model","volume":"41","author":"Gugliandolo","year":"2018","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib67","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm.2679","article-title":"Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis","volume":"18","author":"Gulbransen","year":"2012","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106276_bib68","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib69","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02199-8","article-title":"Chronic colitis exacerbates NLRP3-dependent neuroinflammation and cognitive impairment in middle-aged brain","volume":"18","author":"He","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106276_bib70","first-page":"1","article-title":"Administration of 17\u03b2-estradiol improves motoneuron survival and down-regulates inflammasome activation in male SOD1(G93A) ALS Mice","volume":"54","author":"Heitzer","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"7434","key":"10.1016\/j.neubiorev.2025.106276_bib71","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2025.106276_bib72","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/21678421.2021.1904994","article-title":"Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls","volume":"23","author":"Hertzberg","year":"2022","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.neubiorev.2025.106276_bib73","doi-asserted-by":"crossref","first-page":"1214289","DOI":"10.3389\/fimmu.2023.1214289","article-title":"Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis","volume":"14","author":"Honda","year":"2023","journal-title":"Front. immunol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib74","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s12035-023-03618-y","article-title":"Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice","volume":"61","author":"Hou","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577543","article-title":"A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease","volume":"354","author":"Huang","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106276_bib76","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/1567205013666160208142456","article-title":"Oral triphenylmethane food dye analog, brilliant blue G, prevents neuronal loss in APPSwDI\/NOS2-\/- mouse model","volume":"13","author":"Irwin","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neubiorev.2025.106276_bib77","first-page":"83","article-title":"NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson\u2019s disease","author":"Javed","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"47","key":"10.1016\/j.neubiorev.2025.106276_bib78","doi-asserted-by":"crossref","first-page":"15811","DOI":"10.1523\/JNEUROSCI.4088-10.2010","article-title":"The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18","volume":"30","author":"Jha","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib79","article-title":"Cathepsin L-containing exosomes from \u03b1-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor","volume":"8","author":"Jiang","year":"2022","journal-title":"NPJ Park.\u2019S. Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib80","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106276_bib81","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72197-y","article-title":"Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract","volume":"10","author":"Johanson","year":"2020","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.neubiorev.2025.106276_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10787-017-0401-9","article-title":"Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain","volume":"26","author":"Khan","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"9769","key":"10.1016\/j.neubiorev.2025.106276_bib85","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet (Lond. Engl.)"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib86","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal Propagation of Pathologic \u03b1-Synuclein from the Gut to the Brain Models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib87","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-022-02586-5","article-title":"Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Neurol."},{"issue":"26","key":"10.1016\/j.neubiorev.2025.106276_bib88","doi-asserted-by":"crossref","first-page":"23262","DOI":"10.1074\/jbc.M102253200","article-title":"Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery","volume":"276","author":"Kim","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib89","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neubiorev.2025.106276_bib90","first-page":"135","article-title":"Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington\u2019s disease","author":"Kong","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2025.106276_bib91","first-page":"148","article-title":"An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington\u2019s disease","author":"Kong","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib92","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3858\/emm.2011.43.1.001","article-title":"Microglial P2X\u2087 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib93","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3892\/mmr.2021.12374","article-title":"Roles of \u03b1-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson\u2019s disease progression","volume":"24","author":"Lei","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neubiorev.2025.106276_bib94","first-page":"88","article-title":"Amifostine ameliorates induction of experimental autoimmune encephalomyelitis: effect on reactive oxygen species\/NLRP3 pathway","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib95","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02995-z","article-title":"Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL\/6 mice","volume":"19","author":"Lin","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neubiorev.2025.106276_bib96","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1100\/tsw.2011.139","article-title":"The multifaceted role of the inflammasome in inflammatory bowel diseases","volume":"11","author":"Lissner","year":"2011","journal-title":"Sci. World J."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib97","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2016.07.039","article-title":"Down-regulation of purinergic P2X7 receptor expression and intracellular calcium dysregulation in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis","volume":"630","author":"Liu","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"PB","key":"10.1016\/j.neubiorev.2025.106276_bib99","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2013.10.051","article-title":"Characterization of the APP\/PS1 mouse model of Alzheimer\u2019s disease in senescence accelerated background","volume":"557","author":"Lok","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11302-020-09692-4","article-title":"The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice","volume":"16","author":"Ly","year":"2020","journal-title":"Purinergic Signal"},{"issue":"15","key":"10.1016\/j.neubiorev.2025.106276_bib101","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/WNL.0000000000002017","article-title":"Basal ganglia pathology in ALS is associated with neuropsychological deficits","volume":"85","author":"Machts","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106276_bib102","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/brain\/awaa084","article-title":"NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients","volume":"143","author":"Malhotra","year":"2020","journal-title":"Brain A J. Neurol."},{"issue":"Pt 3","key":"10.1016\/j.neubiorev.2025.106276_bib103","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/brain\/awu388","article-title":"NLRP3 inflammasome is associated with the response to IFN-\u03b2 in patients with multiple sclerosis","volume":"138","author":"Malhotra","year":"2015","journal-title":"Brain A J. Neurol."},{"issue":"7081","key":"10.1016\/j.neubiorev.2025.106276_bib104","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41380-018-0108-3","article-title":"New role of P2X7 receptor in an Alzheimer\u2019s disease mouse model","volume":"24","author":"Martin","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106276_bib106","first-page":"13","article-title":"Amyloid peptide induced neuroinflammation increases the P2X7 receptor expression in microglial cells, impacting on its functionality","author":"Mart\u00ednez-Frailes","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00281-007-0079-y","article-title":"NALP inflammasomes: a central role in innate immunity","volume":"29","author":"Martinon","year":"2007","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib108","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.633861","article-title":"P2X7 Receptor Agonist 2\u2019(3\u2019)-O-(4-Benzoylbenzoyl)ATP differently modulates cell viability and corticostriatal synaptic transmission in experimental models of Huntington\u2019s Disease","volume":"11","author":"Martire","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib110","article-title":"Huntington\u2019s disease: a clinical primer for acute and general physicians","volume":"24","author":"Massey","year":"2024","journal-title":"Clin. Med. (Lond. Engl. )"},{"key":"10.1016\/j.neubiorev.2025.106276_bib111","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/MCG.0000000000001042","article-title":"Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies","volume":"52","author":"Mazzini","year":"2018","journal-title":"J. Clin. Gastroenterol."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106276_bib112","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/01.jnen.0000240470.97295.d3","article-title":"Upregulated expression of purinergic P2X(7) receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus","volume":"65","author":"McLarnon","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7164","key":"10.1016\/j.neubiorev.2025.106276_bib113","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2025.106276_bib114","first-page":"57","article-title":"Molecular characterization of the gut microbiome in egyptian patients with remitting relapsing multiple sclerosis","author":"Mekky","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/biomedicines13020327","article-title":"Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies","volume":"13","author":"Meng","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.neubiorev.2025.106276_bib116","doi-asserted-by":"crossref","unstructured":"Meredith, G.E., & Rademacher, D.J. (2011). MPTP Mouse Models of Parkinson\u2019s Disease: An Update. https:\/\/doi.org\/10.3233\/JPD-2011-11023.","DOI":"10.3233\/JPD-2011-11023"},{"issue":"13","key":"10.1016\/j.neubiorev.2025.106276_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/cells12131786","article-title":"Astroglial cell-to-cell interaction with autoreactive immune cells in experimental autoimmune Encephalomyelitis involves P2X7 Receptor, \u03b23-Integrin, and Connexin-43","volume":"12","author":"Milicevic","year":"2023","journal-title":"Cells"},{"issue":"Pt 4","key":"10.1016\/j.neubiorev.2025.106276_bib118","article-title":"Yeast \u03b2-glucan alleviates high-fat diet-induced Alzheimer\u2019s disease-like pathologies in rats via the gut-brain axis","volume":"278","author":"Mo","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib119","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.neubiorev.2025.106276_bib120","first-page":"13","article-title":"Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis","author":"Moles","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106276_bib121","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/acschemneuro.0c00695","article-title":"Gut microbiota changes in experimental autoimmune encephalomyelitis and cuprizone mice models","volume":"12","author":"Moles","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib122","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","article-title":"Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons","volume":"145","author":"Moonen","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106276_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22052523","article-title":"Inflammasome in ALS skeletal muscle: NLRP3 as a potential biomarker","volume":"22","author":"Moreno-Garc\u00eda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2025.106276_bib124","unstructured":"Multiple sclerosis Fact Sheets, World Health Organization (WHO). (2023). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/multiple-sclerosis."},{"key":"10.1016\/j.neubiorev.2025.106276_bib125","unstructured":"Multiple Sclerosis| National Institute of Neurological Disorders and Stroke. (2023). https:\/\/www.ninds.nih.gov\/health-information\/disorders\/multiple-sclerosis."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106276_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050930","article-title":"Gut microbiota as a potential predictive biomarker in relapsing-remitting multiple sclerosis","volume":"13","author":"Navarro-L\u00f3pez","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.neubiorev.2025.106276_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105760","article-title":"The misfolding mystery: \u03b1-synuclein and the pathogenesis of Parkinson\u2019s disease","volume":"177","author":"Negi","year":"2024","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbrc.2013.03.079","article-title":"Silencing of the P2X(7) receptor enhances amyloid-\u03b2 phagocytosis by microglia","volume":"434","author":"Ni","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106276_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070753","article-title":"The gut microbiota-immunity axis in ALS: a role in deciphering disease heterogeneity","volume":"9","author":"Niccolai","year":"2021","journal-title":"Biomedicines"},{"issue":"3\u20134","key":"10.1016\/j.neubiorev.2025.106276_bib130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","article-title":"The human gut microbiota in people with amyotrophic lateral sclerosis","volume":"22","author":"Nicholson","year":"2021","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"issue":"1700","key":"10.1016\/j.neubiorev.2025.106276_bib131","article-title":"P2X receptors. Philosophical Transactions of the Royal Society of London","volume":"371","author":"North","year":"2016","journal-title":"Ser. B Biol. Sci."},{"issue":"40","key":"10.1016\/j.neubiorev.2025.106276_bib132","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106276_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12121253","article-title":"Target metabolites to slow down progression of amyotrophic lateral sclerosis in mice","volume":"12","author":"Ogbu","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.neubiorev.2025.106276_bib134","first-page":"13","article-title":"Molecular pharmacology of P2X receptors: exploring druggable domains revealed by structural biology","author":"Oken","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.567430","article-title":"P2X7 receptor upregulation in Huntington\u2019s Disease Brains","volume":"13","author":"Oll\u00e0","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106276_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s Disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-020-00293-z","article-title":"Pyroptotic cell death in the R6\/2 mouse model of Huntington\u2019s disease: new insight on the inflammasome","volume":"6","author":"Paldino","year":"2020","journal-title":"Cell Death Discov."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106276_bib138","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ana.26753","article-title":"Microglial and astrocytic responses in the human midcingulate cortex in Huntington\u2019s Disease","volume":"94","author":"Palpagama","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib139","unstructured":"Parkinson Disease Key Facts, WHO. (2023). \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease\u3009."},{"key":"10.1016\/j.neubiorev.2025.106276_bib140","unstructured":"Parkinson\u2019s Disease | National Institute of Neurological Disorders and Stroke. (2024). \u3008https:\/\/www.ninds.nih.gov\/health-information\/disorders\/parkinsons-disease\u3009."},{"key":"10.1016\/j.neubiorev.2025.106276_bib141","unstructured":"Parkinson\u2019s Disease: Causes, Symptoms, and Treatments | National Institute on Aging. (2022). \u3008https:\/\/www.nia.nih.gov\/health\/parkinsons-disease\/parkinsons-disease-causes-symptoms-and-treatments\u3009."},{"key":"10.1016\/j.neubiorev.2025.106276_bib142","first-page":"15","article-title":"Gut microbiota and intestinal barrier function in subjects with cognitive impairments: a cross-sectional study","author":"Pei","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106276_bib143","first-page":"187","article-title":"P2X7 receptor and the NLRP3 inflammasome: Partners in crime","author":"Pelegrin","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib144","first-page":"191","article-title":"Microbiota-gut-brain axis in health and disease: is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications","author":"Pellegrini","year":"2020","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00401-018-1856-5","article-title":"Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases","volume":"136","author":"Pellegrini","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib146","article-title":"Enteric \u03b1-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson\u2019s disease before brain pathology","volume":"8","author":"Pellegrini","year":"2022","journal-title":"NPJ Park. \u2019S. Dis."},{"key":"10.1016\/j.neubiorev.2025.106276_bib147","first-page":"1","article-title":"Role of peripheral NLRP3 inflammasome in cognitive impairments: insights of non-central factors","volume":"2025","author":"Qiao","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib148","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bbi.2020.10.010","article-title":"Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson\u2019s disease","volume":"91","author":"Qin","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106276_bib149","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1007\/s12035-025-04726-7","article-title":"Short-chain fatty acid aggregates alpha-synuclein accumulation and neuroinflammation via GPR43-NLRP3 signaling pathway in a model Parkinson\u2019s Disease","volume":"62","author":"Qu","year":"2025","journal-title":"Mol. neurobiol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib150","article-title":"Genetic phenotypes of Alzheimer\u2019s disease: mechanisms and potential therapy","author":"Quan","year":"2023","journal-title":"Phenomics 2023 34 3(4) 333349"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib151","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-017-2573-y","article-title":"P2X7 receptor mediates NLRP3-dependent IL-1\u03b2 secretion and parasite proliferation in Toxoplasma gondii-infected human small intestinal epithelial cells","volume":"11","author":"Quan","year":"2018","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.neubiorev.2025.106276_bib152","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fneur.2020.00137","article-title":"Gut microbiota altered in mild cognitive impairment compared with normal cognition in sporadic Parkinson\u2019s Disease","volume":"11","author":"Ren","year":"2020","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106276_bib153","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acschemneuro.1c00095","article-title":"Depression induced by chronic unpredictable mild stress increases susceptibility to Parkinson\u2019s Disease in mice via neuroinflammation mediated by P2X7 receptor","volume":"12","author":"Ren","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106276_bib154","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.144","article-title":"ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation","volume":"3","author":"Riteau","year":"2012","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106276_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051116","article-title":"The Role of Purinergic P2X7 receptor in inflammation and cancer: novel molecular insights and clinical applications","volume":"14","author":"Rotondo","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib156","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00396-2","article-title":"P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice","volume":"15","author":"Ruan","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106276_bib157","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bpa.12426","article-title":"Huntington\u2019s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain","volume":"26","author":"R\u00fcb","year":"2016","journal-title":"Brain Pathol. (Zur. Switz. )"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106276_bib158","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.045732","article-title":"Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1G93A female mice","volume":"13","author":"Ruiz-Ruiz","year":"2020","journal-title":"Dis. Models Mech."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib159","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/apm.13089","article-title":"Pathogen-associated molecular patterns and extracellular Hsp70 interplay in NLRP3 inflammasome activation in monocytic and bronchial epithelial cellular models of COPD exacerbations","volume":"129","author":"Rumora","year":"2021","journal-title":"APMIS Acta Pathol. Microbiol. Et. Immunol. Scand."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11011-021-00857-7","article-title":"A novel probiotic strain exerts therapeutic effects on mouse model of multiple sclerosis by altering the expression of inflammasome and IDO genes and modulation of T helper cytokine profile","volume":"37","author":"Sadeghirashed","year":"2022","journal-title":"Metab. Brain Dis."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106276_bib161","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"FEB","key":"10.1016\/j.neubiorev.2025.106276_bib162","article-title":"Principles and properties of ion flow in P2X receptors","volume":"8","author":"Samways","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106276_bib163","first-page":"2024","article-title":"The plasticity of immune cell response complicates dissecting the underlying pathology of multiple sclerosis","author":"Sarkar","year":"2024","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.neubiorev.2025.106276_bib164","first-page":"71","article-title":"Alterations of the gut mycobiome in patients with MS","author":"Shah","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neubiorev.2025.106276_bib165","first-page":"13","article-title":"Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis","author":"Shahi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib166","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neures.2018.06.002","article-title":"Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer\u2019s disease model mouse","volume":"143","author":"Shang","year":"2019","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2025.106276_bib167","first-page":"100","article-title":"New mechanism of neuroinflammation in Alzheimer\u2019s disease: The activation of NLRP3 inflammasome mediated by gut microbiota","author":"Shen","year":"2020","journal-title":"Prog. NeuroPsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040779","article-title":"Alterations in the gut-microbial-inflammasome-brain axis in a mouse model of Alzheimer\u2019s Disease","volume":"10","author":"Shukla","year":"2021","journal-title":"Cells"},{"issue":"16","key":"10.1016\/j.neubiorev.2025.106276_bib169","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.3390\/ijms22168404","article-title":"Astroglial and microglial purinergic P2X7 receptor as a major contributor to neuroinflammation during the course of multiple sclerosis","volume":"22","author":"Sidoryk-W\u0119grzynowicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11441-0","article-title":"Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease","volume":"10","author":"Siew","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106276_bib171","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","article-title":"Inflammasome assembly in neurodegenerative diseases","volume":"46","author":"Singh","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106276_bib172","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/5584_2017_59","article-title":"The P2X7 receptor","volume":"1051","author":"Sluyter","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106276_bib173","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/ene.14918","article-title":"P2X7 receptor\/NLRP3 inflammasome complex and \u03b1-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-na\u00efve Parkinson\u2019s disease","volume":"28","author":"Solini","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib174","first-page":"13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997"},{"key":"10.1016\/j.neubiorev.2025.106276_bib175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbi.2022.08.003","article-title":"Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP\/PS1 mice","volume":"106","author":"Sun","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106276_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239584","article-title":"Familial Alzheimer\u2019s disease mutations at position 22 of the amyloid \u03b2-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system","volume":"15","author":"Tackenberg","year":"2020","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106276_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/genes12111753","article-title":"Investigating markers of the NLRP3 inflammasome pathway in Alzheimer\u2019s disease: a human post-mortem study","volume":"12","author":"Tang","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.neubiorev.2025.106276_bib178","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/B978-0-12-385526-8.00015-1","article-title":"Role of purinergic receptors in CNS function and neuroprotection","volume":"61","author":"Tozaki-Saitoh","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib179","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106276_bib180","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1073\/pnas.93.7.3155","article-title":"Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions","volume":"93","author":"Tu","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib181","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","article-title":"Age-dependent cognitive decline in the APP23 model precedes amyloid deposition","volume":"17","author":"Van Dam","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib182","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-022-02466-9","article-title":"Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex","volume":"144","author":"Van Schoor","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib183","unstructured":"Ventyx Biosciences. (2025). VTX3232: Novel CNS-penetrant NLRP3 inhibitor with best-in-class potential in NLRP3-mediated neuroinflammatory and neurodegenerative diseases. \u3008https:\/\/ventyxbio.com\/pipeline\/#VTX2735\u3009."},{"key":"10.1016\/j.neubiorev.2025.106276_bib184","series-title":"Amyotrophic Lateral Sclerosis","article-title":"Clinical manifestation and management of amyotrophic lateral sclerosis","author":"Verma","year":"2021"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib185","article-title":"NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson\u2019s disease","volume":"4","author":"von Herrmann","year":"2018","journal-title":"NPJ Park. \u2019S. Dis."},{"key":"10.1016\/j.neubiorev.2025.106276_bib186","doi-asserted-by":"crossref","DOI":"10.1007\/s12602-025-10499-1","article-title":"Akkermansia muciniphila Akk11 supplementation attenuates MPTP-Induced Neurodegeneration by Inhibiting Microglial NLRP3 Inflammasome","author":"Wang","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib187","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3892\/mmr.2016.6070","article-title":"Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson\u2019s disease","volume":"15","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neubiorev.2025.106276_bib188","first-page":"129","article-title":"The gut microbiota attenuate neuroinflammation in manganese exposure by inhibiting cerebral NLRP3 inflammasome","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib189","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/aps.2015.127","article-title":"Insights into the channel gating of P2X receptors from structures, dynamics and small molecules","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib190","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4103\/1673-5374.323077","article-title":"The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson\u2019s disease","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib191","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/acs.jafc.1c07711","article-title":"Lactobacillus plantarum DP189 Reduces \u03b1-SYN Aggravation in MPTP-Induced Parkinson\u2019s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder","volume":"70","author":"Wang","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib192","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa110","article-title":"Gut dysbiosis in Huntington\u2019s disease: associations among gut microbiota, cognitive performance and clinical outcomes","volume":"2","author":"Wasser","year":"2020","journal-title":"Brain Commun."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106276_bib193","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113959","article-title":"P2X7 receptor is involved in mitochondrial dysfunction induced by extracellular alpha synuclein in neuroblastoma SH-SY5Y Cells","volume":"21","author":"Wilkaniec","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib194","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12356","article-title":"Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model","volume":"3","author":"Wu","year":"2015","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib195","first-page":"1","article-title":"Peripheral proteinopathy in neurodegenerative diseases","volume":"14","author":"Xu","year":"2025","journal-title":"Transl. Neurodegener. 2025 141"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106276_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264556","article-title":"Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness","volume":"17","author":"Yadav","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.neubiorev.2025.106276_bib197","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1015372","article-title":"Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis","volume":"13","author":"Yadav","year":"2022","journal-title":"Front. immunol."},{"issue":"27","key":"10.1016\/j.neubiorev.2025.106276_bib198","doi-asserted-by":"crossref","first-page":"30557","DOI":"10.1021\/acsami.2c06283","article-title":"Multifunctional selenium nanoparticles with different surface modifications ameliorate neuroinflammation through the gut microbiota-NLRP3 inflammasome-brain axis in APP\/PS1 mice","volume":"14","author":"Yang","year":"2022","journal-title":"ACS appl. mater. interfaces"},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106276_bib199","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70003","article-title":"Fecal microbiota from patients with Parkinson\u2019s disease intensifies inflammation and neurodegeneration in A53T mice","volume":"30","author":"Yang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neubiorev.2025.106276_bib200","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.csbj.2023.03.017","article-title":"Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis","volume":"21","author":"Yang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.neubiorev.2025.106276_bib201","first-page":"6","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106276_bib202","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","article-title":"NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer\u2019s disease","volume":"55","author":"Yin","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2025.106276_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib204","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-022-00733-9","article-title":"Spatiotemporal evolution of pyroptosis and canonical inflammasome pathway in hSOD1G93A ALS mouse model","volume":"23","author":"Zhang","year":"2022","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib205","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1996848","article-title":"Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis","volume":"13","author":"Zhang","year":"2021","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106276_bib206","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","article-title":"Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis","volume":"39","author":"Zhang","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neubiorev.2025.106276_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106530","article-title":"The role of microbiota-mitochondria crosstalk in pathogenesis and therapy of intestinal diseases","volume":"186","author":"Zhang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2025.106276_bib208","first-page":"764","article-title":"Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in A\u03b21-42-induced microglia cells","author":"Zhang","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2025.106276_bib209","first-page":"14","article-title":"Astrocytic and oligodendrocytic P2X7 receptors determine neuronal functions in the CNS","author":"Zhao","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106276_bib210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11481-024-10163-5","article-title":"Modulation of intestinal inflammation and protection of dopaminergic neurons in Parkinson\u2019s disease mice through a probiotic formulation targeting NLRP3 inflammasome","volume":"20","author":"Zhou","year":"2025","journal-title":"J. NeuroImmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425002775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425002775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:19:52Z","timestamp":1772749192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425002775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":210,"alternative-id":["S0149763425002775"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106276","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106276"}}